NCT04867408Recruiting
Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease (EVEREST - IBD)
EVEREST - IBD: Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease
Source: ClinicalTrials.gov · Last updated 15 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To develop and train a convolutional neural network to detect and characterize disease severity of inflammatory bowel disease during endoscopy
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 4000 (estimated)
- First submitted
- 27 Apr 2021
- Start date
- 17 Sept 2021
- Primary completion date
- 30 Sept 2031
- Lead sponsor
- Hull University Teaching Hospitals NHS Trust
- Diseases
- Crohn's disease
- NCT number
- NCT04867408
What you commit to
- Study type: Observational
- Planned participants: 4000
- From 17 Sept 2021 to the primary completion date, 30 Sept 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- • Any patient under the age of 16
- Patients who are unable to give informed consent to undergo endoscopic investigation or those who do not wish their pseudo-anonymised images to be used
Who the study is looking for
- • Any adult patient aged 16 years or older who has consented to undergo endoscopic investigation where images are captured as part of routine clinical care.
Age in the registry: 16 years to 99 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hull Royal Infirmary Coordinator of this site? Confirm its status | Hull | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.